- Home
- LIDR vs COYA Comparison
LIDR vs COYA Comparison
Compare LIDR & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- COYA
- Stock Information
- Founded
- LIDR 2013
- COYA 2020
- Country
- LIDR United States
- COYA United States
- Employees
- LIDR N/A
- COYA N/A
- Industry
- LIDR Auto Parts:O.E.M.
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- COYA Health Care
- Exchange
- LIDR Nasdaq
- COYA Nasdaq
- Market Cap
- LIDR 105.4M
- COYA 107.0M
- IPO Year
- LIDR N/A
- COYA 2022
- Fundamental
- Price
- LIDR $2.57
- COYA $6.12
- Analyst Decision
- LIDR Strong Buy
- COYA Strong Buy
- Analyst Count
- LIDR 1
- COYA 5
- Target Price
- LIDR $6.00
- COYA $16.20
- AVG Volume (30 Days)
- LIDR 5.6M
- COYA 298.9K
- Earning Date
- LIDR 11-06-2025
- COYA 11-06-2025
- Dividend Yield
- LIDR N/A
- COYA N/A
- EPS Growth
- LIDR N/A
- COYA N/A
- EPS
- LIDR N/A
- COYA N/A
- Revenue
- LIDR $236,000.00
- COYA $423,452.00
- Revenue This Year
- LIDR $1.50
- COYA $40.80
- Revenue Next Year
- LIDR $2,806.06
- COYA N/A
- P/E Ratio
- LIDR N/A
- COYA N/A
- Revenue Growth
- LIDR N/A
- COYA N/A
- 52 Week Low
- LIDR $0.49
- COYA $4.65
- 52 Week High
- LIDR $6.44
- COYA $8.29
- Technical
- Relative Strength Index (RSI)
- LIDR 44.29
- COYA 47.01
- Support Level
- LIDR $2.36
- COYA $6.07
- Resistance Level
- LIDR $2.83
- COYA $6.77
- Average True Range (ATR)
- LIDR 0.27
- COYA 0.62
- MACD
- LIDR -0.04
- COYA -0.05
- Stochastic Oscillator
- LIDR 16.67
- COYA 15.10
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.